NAKATA JUN 中田潤

… Alternative Names

Nakata Jun 中田潤

Jun Nakata 中田潤

Less

Researcher Number	90528952
Other IDs
Affiliation (Current)	2025: 大阪大学, 大学院医学系研究科, 助教
Affiliation (based on the past Project Information) *help	2019 – 2021: 大阪大学, 医学系研究科, 助教 2016 – 2017: 大阪大学, 医学系研究科, 寄附講座助教 2015: 大阪大学, 医学(系)研究科(研究院), 寄附講座助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Hematology
Keywords	Principal Investigator 腫瘍免疫 / ヘルパーペプチド / WT1 / 癌免疫 / Immunotherapy / TIL / 腫瘍内免疫細胞 / 癌ワクチン療法 / 抑制性マクロファージ / WT1ペプチドワクチン … More / ペプチドワクチン / ペプチドワクチン療法 / 癌免疫療法 / 急性骨髄性白血病 / WT1ワクチン / 白血病 / 併用療法 / 癌ワクチン / マウス白血病モデル Less

Research for the way to enhance the infiltration of tumor antigen specific CTLs into tumorsPrincipal Investigator
- Principal Investigator
  
  Nakata Jun
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Osaka University
Establishment of a mouse leukemia model and the exploring the way to enhance the anti-leukemia immunity using this mouse leukemia model.Principal Investigator
- Principal Investigator
  
  Jun Nakata
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University

All 2021 2018 2017 2016 2015

All Journal Article Presentation

[Journal Article] Identification of mouse helper epitopes for WT1-specific CD4+ T cells2021
- Author(s)
  Nakajima Hiroko、Nakata Jun、Imafuku Kanako、Hayashibara Hiromu、Isokawa Kazuki、Udaka Keiko、Fujiki Fumihiro、Morimoto Soyoko、Hasegawa Kana、Hosen Naoki、Hashii Yoshiko、Nishida Sumiyuki、Tsuboi Akihiro、Oka Yoshihiro、Oji Yusuke、Sogo Shinji、Sugiyama Haruo
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 70 Issue: 11 Pages: 3323-3335
- DOI
  10.1007/s00262-021-03003-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K16863, KAKENHI-PROJECT-21H02966, KAKENHI-PROJECT-19K07775
[Journal Article] Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.2017
- Author(s)
  Nakata J, Nakae Y, Kawakami M, Morimoto S, Motooka D, Hosen N, Fujiki F, Nakajima H, Hasegawa K, Nishida S, Tsuboi A, Oji Y, Oka Y, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Br J Haematol.
  
  Volume: XX Issue: 2 Pages: 287-290
- DOI
  10.1111/bjh.14768
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K07216, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-15K19550
[Journal Article] Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.2016
- Author(s)
  Oji Y, Hashimoto N, Tsuboi A, Murakami Y, Iwai M, Kagawa N, Chiba Y, Izumoto S, Elisseeva O, Ichinohasama R, Sakamoto J, Morita S, Nakajima H, Takashima S, Nakae Y, Nakata J, Kawakami M, Nishida S, Hosen N, Fujiki F, Morimoto S, Adachi M, Iwamoto M, Oka Y, Yoshimine T, Sugiyama H.
- Journal Title
  
  Int J Cancer.
  
  Volume: 139 Issue: 6 Pages: 1391-401
- DOI
  10.1002/ijc.30182
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25462257, KAKENHI-PROJECT-26430162, KAKENHI-PROJECT-26462195, KAKENHI-PROJECT-15K18446, KAKENHI-PROJECT-15K08609, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-15K10331, KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-15K19550
[Journal Article] An essential role of the avidity of T-cell receptor in differentiation of self-antigen-reactive CD8+ T cells2016
- Author(s)
  Kondo K, Fujiki F, Nakajima H, Yatsukawa E, Morimoto S, Tatsumi N, Nishida S, Nakata J, Oka Y, Tsuboi A, Hosen N, Oji Y, Sugiyama H
- Journal Title
  
  Journal of Immunotherapy
  
  Volume: 39 Issue: 3 Pages: 127-139
- DOI
  10.1097/cji.0000000000000114
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-26430162, KAKENHI-PROJECT-15K18446, KAKENHI-PROJECT-15K19550, KAKENHI-PROJECT-25460685
[Journal Article] Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine2016
- Author(s)
  Takashima S, Oka Y, Fujiki F, Morimoto S, Nakajima H, Nakae Y, Nakata J, Nishida S, Hosen N, Tatsumi N, Mizuguchi K, Hashimoto N, Oji Y, Tsuboi A, Kumanogoh A, Sugiyama H
- Journal Title
  
  Future Sci OA
  
  Volume: FSO96 Issue: 4
- DOI
  10.4155/fsoa-2015-0008
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430162, KAKENHI-PROJECT-15K18446, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K19550
[Journal Article] Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients2015
- Author(s)
  Nakae Y., Oka Y., Fujiki F., Morimoto S., Kamiya T., Takashima S., Nakata J., Nishida S., Nakajima H., Hosen N., Tsuboi A, Kyo T., Oji Y., Mizuguchi K., Kumanogoh A., Sugiyama H.
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: in press Issue: 7 Pages: 791-804
- DOI
  10.1007/s00262-015-1683-7
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24591164, KAKENHI-PROJECT-25830116, KAKENHI-PROJECT-26430162, KAKENHI-PROJECT-15K19550
[Presentation] CD11b+CD64+Ly6c-Ly6G- monocytic cells in skin vaccinated with anti-cancer peptide could be a target to prolong anti-cancer immunity by cancer vaccination.2021
- Author(s)
  Jun Nakata
- Organizer
  マクロファージ分子細胞生物学国際シンポジウム
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K16863
[Presentation] WT1 vaccine therapy against AML: combination strategy for the next step.2018
- Author(s)
  Nakata J, Nakajima H, Nakae Y, Mizutani Y, Imafuku K, Morimoto S, Fujiki F, Kawakami Y, Nishida S, Hosen N, Tsuboi A, Oji Y, Oka Y, Kumanogoh A, Sugiyama H
- Organizer
  Cancer Immunotherapy: Combinations (C5) in Keystone Symposia
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19550
[Presentation] 急性骨髄性白血病に対するWT1ワクチン療法の進捗2017
- Author(s)
  中田潤、中江吉希、川上学、森本創世子、元岡大祐、水谷陽、保仙直毅、藤木文博、中島博子、長谷川加奈、西田純幸、坪井昭博、尾路祐介、岡芳弘、杉山治夫
- Organizer
  第9回　血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-15K19550
[Presentation] WT1 peptide vaccination could be a maintenance therapy for AML patients with high risk of relapse2016
- Author(s)
  中田潤
- Organizer
  日本血液学会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-15K19550
[Presentation] 急性骨髄性白血病に対するWT1ワクチン療法2016
- Author(s)
  中田潤
- Organizer
  血液疾患免疫療法学会
- Place of Presentation
  北海道大学医学部学友会館「フラテ」
- Data Source
  KAKENHI-PROJECT-15K19550
[Presentation] 急性骨髄性白血病に対するWT1ワクチン療法2015
- Author(s)
  中田潤、中江吉希、川上学、森本創世子、藤木文博、中島博子、西田純幸、保仙直毅、坪井昭博、尾路祐介、岡芳弘、杉山治夫
- Organizer
  第7回　血液免疫療法研究会
- Place of Presentation
  東京大学　伊藤謝恩ホール
- Year and Date
  2015-09-26
- Data Source
  KAKENHI-PROJECT-15K19550
[Presentation] WT1 peptide-based immunotherapy as post-chemotherapy treatment in adult AML patients at high risk of relapse2015
- Author(s)
  Jun Nakata, Yoshiki Nakae, Manabu Kawakami, Soyoko Morimoto, Fumihiro Fujiki, Hiroko Nakajima, Sumiyuki Nishida, Naoki Hosen, Akihiro Tsuboi, Yuske Oji, Yoshihiro Oka, Haruo Sugiyama
- Organizer
  The 8th internatinal conference on WT1 in human neoplasia
- Place of Presentation
  KBS Kyoto Hall, Kyoto, Japan
- Year and Date
  2015-11-19
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19550

1. TSUBOI Akihiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. CHIBA Yasuyoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. NISHIDA Sumiyuki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. Morimoto Soyoko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. FUJIKI Fumihiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. 橋本直哉

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 岡芳弘

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

NAKATA JUN 中田 潤

Nakata Jun 中田 潤

Jun Nakata 中田 潤

Research Projects

Research Products

Co-Researchers

Research for the way to enhance the infiltration of tumor antigen specific CTLs into tumorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of a mouse leukemia model and the exploring the way to enhance the anti-leukemia immunity using this mouse leukemia model.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Identification of mouse helper epitopes for WT1-specific CD4+ T cells2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] An essential role of the avidity of T-cell receptor in differentiation of self-antigen-reactive CD8+ T cells2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients2015

Author(s)

Journal Title

DOI

Data Source

[Presentation] CD11b+CD64+Ly6c-Ly6G- monocytic cells in skin vaccinated with anti-cancer peptide could be a target to prolong anti-cancer immunity by cancer vaccination.2021

Author(s)

Organizer

Data Source

[Presentation] WT1 vaccine therapy against AML: combination strategy for the next step.2018

Author(s)

Organizer

Data Source

[Presentation] 急性骨髄性白血病に対するWT1ワクチン療法の進捗2017

Author(s)

Organizer

Data Source

[Presentation] WT1 peptide vaccination could be a maintenance therapy for AML patients with high risk of relapse2016

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 急性骨髄性白血病に対するWT1ワクチン療法2016

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 急性骨髄性白血病に対するWT1ワクチン療法2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] WT1 peptide-based immunotherapy as post-chemotherapy treatment in adult AML patients at high risk of relapse2015

Author(s)

Organizer

Place of Presentation

NAKATA JUN 中田潤

Nakata Jun 中田潤

Jun Nakata 中田潤